Clinical trialCLINICALTRIALSMar 26
New Clinical Trial: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)
Researchers are testing two cancer-fighting drugs called nivolumab and ipilimumab together to treat patients with rare types of cancer. These drugs help the body's immune system recognize and fight cancer cells. The trial is currently active but not accepting new patients at this time.
WHY IT MATTERSThis trial tests a combination immunotherapy approach across 50+ rare tumor types, offering potential treatment options for patients with uncommon cancers that have limited standard therapies available.